Avantor, Inc.
Business
Avantor is a leading global provider of mission-critical products and services to customers in biopharma & healthcare, education & government, and advanced technologies & applied materials. The company offers consumables, equipment, and value-added services through its VWR distribution channel, and manufactures proprietary products including J.T. Baker chemicals, Masterflex fluid-handling systems, and NuSil silicones. It operates through two reportable segments—Laboratory Solutions and Bioscience Production—serving over 300,000 customer locations across approximately 180 countries via manufacturing, distribution, and service infrastructure.
Summary from 10-K filed 2026-02-11
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Net sales | 6,552 | 6,784 | 6,967 | 7,512 | 7,386 | |
| Cost of sales | 4,413 | 4,504 | 4,603 | 4,910 | 4,883 | |
| Gross profit | 2,139 | 2,279 | 2,364 | 2,603 | 2,503 | |
| Selling, general and administrative expenses | 1,596 | 1,641 | 1,507 | 1,473 | 1,531 | |
| Impairment charges | 785 | 0 | 161 | 0 | 0 | |
| Gain on sale of business | 5 | −447 | 0 | 0 | — | |
| Operating (loss) income | −246 | 1,085 | 696 | 1,130 | 972 | |
| Interest expense, net | −170 | −219 | −285 | −266 | — | |
| Loss on extinguishment of debt | −5 | −11 | −7 | −13 | −12 | |
| Other (expense) income, net | −21 | −1 | 6 | −800,000 | 11 | |
| (Loss) income before income taxes | −441 | 854 | 411 | 851 | 753 | |
| Income tax expense | −89 | −142 | −89 | −165 | −180 | |
| Net (loss) income | −530 | 712 | 321 | 687 | 573 | |
| Basic (in dollars per share) | −0.78 | 1.05 | 0.48 | 1.02 | 0.86 | |
| Diluted Basic (in dollars per share) | −0.78 | 1.04 | 0.47 | 1.01 | 0.85 | |
| Basic (in shares) | 681 | 680 | 676 | 651 | 591 | |
| Diluted (in shares) | 681 | 682 | 678 | 679 | 600 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 365 | 262 | 263 | 373 | 302 | |
| Accounts receivable, net of allowances of $29.6 and $30.2 | 1,075 | 1,035 | 1,150 | 1,218 | 1,222 | |
| Inventory | 818 | 732 | 828 | 914 | 872 | |
| Other current assets | 193 | 119 | 144 | 153 | 81 | |
| Total current assets | 2,451 | 2,147 | 2,385 | 2,658 | 2,477 | |
| Property, plant and equipment, net (see note 10) | 767 | 708 | 738 | 727 | 706 | |
| Other intangible assets, net (see note 11) | 3,194 | 3,360 | 3,775 | 4,133 | 5,140 | |
| Goodwill, net (see note 11) | 4,987 | 5,539 | 5,717 | 5,653 | 5,341 | |
| Other assets | 396 | 360 | 358 | 294 | 233 | |
| Total assets | 11,795 | 12,115 | 12,973 | 13,464 | 13,897 | |
| Current portion of debt | 31 | 821 | 260 | 364 | 45 | |
| Accounts payable | 742 | 663 | 626 | 758 | 755 | |
| Employee-related liabilities | 163 | 168 | 133 | 122 | 200 | |
| Accrued interest | 47 | 49 | 50 | 50 | 50 | |
| Other current liabilities | 396 | 307 | 411 | 364 | 401 | |
| Total current liabilities | 1,379 | 2,008 | 1,480 | 1,659 | 1,451 | |
| Debt, net of current portion | 3,916 | 3,235 | 5,277 | 5,923 | 6,978 | |
| Deferred income tax liabilities | 557 | 557 | 613 | 731 | 913 | |
| Other liabilities | 378 | 358 | 350 | 295 | 358 | |
| Total liabilities | 6,230 | 6,158 | 7,720 | 8,609 | 9,700 | |
| Commitments and contingencies (see note 13) | — | — | — | — | — | |
| Common stock including paid-in capital, 682.0 and 680.8 shares issued and outstanding | 3,985 | 3,938 | 3,830 | 3,785 | 2,753 | |
| Treasury stock at cost, 6.6 and 0.0 shares | −76 | 0 | — | — | — | |
| Accumulated earnings | 1,673 | 2,203 | 1,492 | 1,170 | 484 | |
| Accumulated other comprehensive loss | −17 | −184 | −69 | −100 | −43 | |
| Total stockholders equity | 5,565 | 5,957 | 5,253 | 4,855 | 4,197 | |
| Total liabilities and stockholders equity | 11,795 | 12,115 | 12,973 | 13,464 | 13,897 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Amortization | 410 | 406 | 402 | 406 | 379 | |
| Stock-based compensation expense | 46 | 47 | 41 | 46 | 51 | |
| Non-cash restructuring charges (see note 12) | 3 | 17 | 0 | 0 | — | |
| Provision for accounts receivable and inventory | 64 | 75 | 85 | 65 | 45 | |
| Deferred income tax expense (benefit) | 8 | −47 | −172 | −69 | −18 | |
| Amortization of deferred financing costs | 9 | 11 | 13 | 16 | 16 | |
| Foreign currency remeasurement loss (gain) | 2 | −300,000 | −3 | 10 | 7 | |
| Pension termination charges | 18 | 9 | 0 | 0 | — | |
| Accounts receivable | 14 | 46 | 77 | −45 | −112 | |
| Inventory | −109 | −19 | 30 | −113 | −130 | |
| Accounts payable | 42 | 60 | −140 | 16 | 65 | |
| Accrued interest | −1 | −2 | 300,000 | 100,000 | 5 | |
| Other assets and liabilities | −144 | −38 | 49 | −179 | 57 | |
| Other | −1 | −300,000 | −700,000 | −7 | 3 | |
| Net cash provided by operating activities | 624 | 841 | 870 | 844 | 954 | |
| Capital expenditures | −129 | −149 | −146 | −133 | −111 | |
| Proceeds from sale of disposal group, net of cash sold | 0 | 585 | 0 | 0 | — | |
| Other | −2 | 3 | 3 | 2 | 4 | |
| Net cash (used in) provided by investing activities | −131 | 439 | −144 | −110 | −4,122 | |
| Debt borrowings | 1,108 | 0 | 0 | 327 | 2,835 | |
| Debt repayments | −1,426 | −1,342 | −846 | −947 | −534 | |
| Payments of debt refinancing fees | −15 | 0 | −2 | −600,000 | −41 | |
| Proceeds received from exercise of stock options | 5 | 69 | 18 | 17 | 83 | |
| Proceeds received from exercise of stock options | −6 | −9 | −14 | — | — | |
| Payments for repurchase of common stock | −75 | 0 | 0 | — | — | |
| Net cash used in financing activities | −409 | −1,281 | −844 | −649 | 3,219 | |
| Effect of currency rate changes on cash and cash equivalents | 20 | −22 | 8 | −16 | −13 | |
| Net change in cash, cash equivalents and restricted cash | 104 | −23 | −109 | 70 | 38 |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is Avantor, Inc.'s CIK number?
Avantor, Inc.'s SEC CIK number is 0001722482 (1722482). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find Avantor, Inc.'s SEC filings?
All of Avantor, Inc.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did Avantor, Inc. last report earnings?
Avantor, Inc. (AVTR) most recently filed an earnings 8-K with the SEC on Apr 29, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001628280-26-028078). This is Avantor, Inc.'s most recent earnings filing of record — not a forecast of its next earnings date.
What is Avantor, Inc.'s most recent earnings 8-K?
Avantor, Inc.'s latest earnings 8-K (Item 2.02) was filed Apr 29, 2026 under accession 0001628280-26-028078. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View Avantor, Inc.'s latest earnings 8-K →
Look up any company's CIK number →